Erasca, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jonathan E. Lim, with a market cap of $4.7B.
Common questions about Erasca, Inc.
Erasca, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026.
Erasca, Inc. has approximately 129 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.